001     186747
005     20240229145750.0
024 7 _ |2 doi
|a 10.1016/j.celrep.2022.111776
024 7 _ |2 ISSN
|a 2211-1247
024 7 _ |2 ISSN
|a 2639-1856
024 7 _ |a altmetric:139745191
|2 altmetric
024 7 _ |a pmid:36476862
|2 pmid
037 _ _ |a DKFZ-2023-00091
082 _ _ |a 610
100 1 _ |0 P:(DE-He78)745106b01fd7e289eb638c8580faeb13
|a Eismann, Lena
|b 0
|e First author
|u dkfz
245 _ _ |a Selective ribosome profiling reveals a role for SecB in the co-translational inner membrane protein biogenesis
260 _ _ |a [New York, NY]
|b Elsevier
|c 2022
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1673859402_31431
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
500 _ _ |a #EA:A250#LA:A250# / DKFZ-ZMBH Alliance
536 _ _ |0 G:(DE-HGF)POF4-311
|a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Fijalkowski, Igor
|b 1
700 1 _ |a Galmozzi, Carla Verónica
|b 2
700 1 _ |0 P:(DE-He78)c35cb105d87332a9980bd8f33f3b420a
|a Koubek, Jiri
|b 3
700 1 _ |0 P:(DE-He78)f90ce79ee8558a35867f6631b982aaf3
|a Tippmann, Frank
|b 4
|u dkfz
700 1 _ |a Van Damme, Petra
|b 5
700 1 _ |0 P:(DE-He78)8b9aa336210db1592efa7400628e5a46
|a Kramer, Günter
|b 6
|e Last author
|u dkfz
773 _ _ |0 PERI:(DE-600)2649101-1
|a 10.1016/j.celrep.2022.111776
|g Vol. 41, no. 10, p. 111776 -
|n 10
|p 111776
|t Cell reports
|v 41
|x 2211-1247
|y 2022
909 C O |o oai:inrepo02.dkfz.de:186747
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)745106b01fd7e289eb638c8580faeb13
|a Deutsches Krebsforschungszentrum
|b 0
|k DKFZ
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)c35cb105d87332a9980bd8f33f3b420a
|a Deutsches Krebsforschungszentrum
|b 3
|k DKFZ
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)f90ce79ee8558a35867f6631b982aaf3
|a Deutsches Krebsforschungszentrum
|b 4
|k DKFZ
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)8b9aa336210db1592efa7400628e5a46
|a Deutsches Krebsforschungszentrum
|b 6
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF4-311
|1 G:(DE-HGF)POF4-310
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Krebsforschung
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2022
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b CELL REP : 2021
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2021-01-26T13:08:57Z
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2021-01-26T13:08:57Z
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Blind peer review
|d 2021-01-26T13:08:57Z
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b CELL REP : 2021
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2022-11-17
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2022-11-17
920 2 _ |0 I:(DE-He78)A250-20160331
|k A250
|l A250 Chaperone und Proteasen
|x 0
920 1 _ |0 I:(DE-He78)A250-20160331
|k A250
|l A250 Chaperone und Proteasen
|x 0
920 0 _ |0 I:(DE-He78)A250-20160331
|k A250
|l A250 Chaperone und Proteasen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A250-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21